SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending as investors weigh significant strategic shifts, including a reorganization into three business units and the creation of a standalone Venmo segment, against ongoing concerns about the stock's long-term performance. While some community members view these structural changes as potential catalysts for unlocking shareholder value and attracting buyout interest, others remain skeptical, pointing to stagnant price action and weak guidance as signs that the company remains a value trap.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors aggressively rotate into memory hardware, fueled by a structural supply-demand imbalance and excitement over HBM's critical role in the AI infrastructure supercycle. The community is actively debating the sustainability of this parabolic ascent, with many bulls highlighting low forward price-to-earnings multiples and massive institutional buying while others express caution regarding potential volatility and cycle exhaustion.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is experiencing significant volatility following a major earnings beat that featured record revenue growth and raised guidance, leading to a polarized debate between institutional investors and retail traders. While bulls are highlighting the company's accelerating AI infrastructure adoption, many in the community are expressing frustration over the stock's muted price action and the ongoing tension between its high valuation and fundamental growth metrics.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as the community debates a strategic 14% workforce reduction aimed at streamlining operations for the AI era and managing expenses. Investors are closely weighing this restructuring against the backdrop of a rally in Bitcoin prices and ongoing legislative optimism surrounding the Clarity Act.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining is trending as investors digest mixed first-quarter financial results while closely monitoring the company's aggressive pivot toward AI and hyperscale data center infrastructure. The community is actively debating the significance of recent hyperscale lease agreements and credit facility expansions, with many bulls focused on long-term execution and contract-backed revenue growth despite near-term earnings volatility.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is seeing heightened activity as market participants closely watch the stock's role as a leveraged proxy for Bitcoin, with community sentiment split between enthusiasm for its aggressive accumulation strategy and skepticism regarding its reliance on dilution and debt. Investors are actively debating the stock's potential movement leading into earnings, with many focusing on whether the company will maintain its BTC buying pace and how the broader regulatory environment for crypto assets will impact its valuation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors focus on the successful energization of the 1.4GW Sweetwater 1 facility and the ongoing debate regarding the company's capital strategy through its ATM offering. While community sentiment remains split between excitement over high-capacity infrastructure developments and impatience for new hyperscaler deals, the stock remains a focal point for those tracking the broader AI power and data center buildout sector.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending following a massive expansion of its AI infrastructure partnership with Yotta Data Services, which is projected to generate significant long-term revenue through a large-scale deployment of high-performance GPU hardware. The community remains hyper-focused on this catalyst as a transformational development, with active discussions debating whether the stock is fundamentally undervalued versus concerns over revenue recognition and historical guidance.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending as investors weigh strong quarterly earnings beats and robust merchant growth against a volatile macroeconomic environment and concerns over market valuation. The community remains divided, with some betting on long-term AI-driven infrastructure gains and share buybacks while others express frustration over institutional selling and persistent price swings.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer shares are gaining attention as investors react to a quarterly earnings beat and reaffirmed full-year guidance, though community sentiment remains divided between optimism over potential pipeline breakthroughs and skepticism regarding long-term patent expirations. Conversations are heavily focused on the company's ability to drive growth through its recent oncology and obesity research, while many traders continue to monitor the stock's stability and dividend yield against ongoing market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Onconetix (NASDAQ:ONCO) Major Shareholder Sells 49,710 Shares of Stock

Onconetix, Inc. (NASDAQ:ONCO - Get Free Report) major shareholder Financial Lp Hrt sold 49,710 shares of the business's stock in a transaction that occurred on Tuesday, April 21st. The stock was sold...

Onconetix (NASDAQ:ONCO) Major Shareholder Acquires $25,284.28 in Stock

Onconetix, Inc. (NASDAQ:ONCO - Get Free Report) major shareholder Financial Lp Hrt purchased 34,636 shares of the firm's stock in a transaction on Friday, April 17th. The shares were acquired at an...

Onconetix (NASDAQ:ONCO) Major Shareholder Financial Lp Hrt Buys 74,350 Shares

Onconetix, Inc. (NASDAQ:ONCO - Get Free Report) major shareholder Financial Lp Hrt bought 74,350 shares of the stock in a transaction dated Tuesday, April 14th. The stock was purchased at an average cost of $0.77 per share, with a total value of $57,249.50. Following the completion of the purchase...

<ul class="summary-bullets"><li>REPL came under pressure after the FDA issued a second Complete Response Letter for RP1 with nivolumab in anti-PD-1-failed melanoma.</li><li>HOTH declined after a $2 million stock offering, along with attached warrants, raised dilution concerns despite recent pipeline updates.</li><li>ONCO is on a major slide after its reverse stock split, while its pending all-stock acquisition of Realbotix has yet to improve investor sentiment.</li></ul>Shares of Replimune (REPL), Hoth Therapeutics (HOTH), and Onconetix (ONCO) hit fresh 52-week lows on Monday following an FDA setback, a discounted offering, and a reverse split that underscored listing-compliance pressure.&nbsp;On Monday,&nbsp;<a href="https://stocktwits.com/symbol/REPL">REPL</a> fell 64%,&nbsp;<a href="https://stocktwits.com/symbol/HOTH">HOTH</a> slipped 1% and&nbsp;<a href="https://stocktwits.com/symbol/ONCO">ONCO</a> declined 27%, while the Health Care Select Sector SPDR Fund (XLV) rose 0.5%.<h2 class="st-heading-2">Regulatory Setback Pressures REPL Shares Again</h2>Pressure on REPL intensified recently after the U.S. Food and Drug Administration (FDA) issued a second Complete Response Letter (CRL) for its lead drug RP1 in combination with Nivolumab in anti-PD-1-failed melanoma, extending regulatory uncertainty that had already followed an earlier CRL last year.The latest development triggered a wave of&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/repl-stock-on-track-to-hit-all-time-lows-here-s-why-this-analyst-slashed-price-target-by-85/cZJFHklRIMD">analyst downgrades</a> across Wall Street. Jefferies said the company faces “a tough road ahead” following the FDA’s response, while BMO Capital said the CRL “lays bare the lack of alignment with the FDA and Replimune” throughout clinical development and warned the revised regulatory pathway may now require additional trials.JPMorgan called the outcome “disappointing,” adding it had previously believed “the totality of the data for RP1 warranted an approval.”&nbsp;<h2 class="st-heading-2">Stock Offering Weighs On HOTH Stock</h2>HOTH declined after the company announced earlier this month a stock offering priced at $0.7 per share, expected to generate about $2 million in gross proceeds before expenses, along with warrants exercisable at $0.85.The financing overshadowed pipeline updates over the past month, when the company reported interim Phase 2 progress for HT-001, a topical therapy to treat skin toxicities caused by epidermal growth factor receptor (EGFR) inhibitor cancer treatments. The trial showed that patients reached the primary efficacy endpoint by the sixth week and demonstrated “strong patient benefit across multiple clinically meaningful measures.”&nbsp;However, shares caught a break in after-hours trading on Monday, jumping over 60%, after preclinical data showed its&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-hoth-stock-up-after-hours-today/cZJ8gnKRIuz">HT-VA (GDNF) therapy</a> improved key gene markers linked to fat production and metabolism and outperformed Novo Nordisk's semaglutide on liver-fat regulation signals.<h2 class="st-heading-2">ONCO Slides Despite Realbotix Merger Progress</h2>ONCO shares have remained weak since the company implemented a 1-for-5 reverse stock split, effective March 25, to maintain compliance with Nasdaq’s minimum bid price requirement.The reverse split followed a September equity raise of $12.9 million through Series D preferred stock and warrants, with proceeds used in part to reduce outstanding debt and support working capital following the termination of a previously planned merger with Ocuvex.In February, the company entered into an agreement to acquire Realbotix in an all-stock transaction expected to close in the second half of 2026. Realbotix reported delivering its first Vinci-equipped humanoid robot to Ericsson this month and said the platform enables robots to “recognize returning users, recall previous conversations, and track engagement.” The company expects deliveries of 19 robots across March, April and May as production scales.<h2 class="st-heading-2">How Do Retail Traders Feel About REPL, HOTH, ONCO?</h2>On Stocktwits, retail sentiment for REPL was ‘bearish’ amid ‘extremely high’ message volume, while sentiment for both HOTH and ONCO remained ‘extremely bullish,’ also accompanied by ‘extremely high’ message volume.Over the past year, REPL has fallen 77%, HOTH down 36% and ONCO declining 97%, with all three stocks underperforming the broader XLV ETF, which rose 10% over the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/immunitybio-founder-fda-warning-letter-anktiva-ad-never-aired/cZJpYnYRIHR">ImmunityBio Founder Pushes Back After FDA Warning Letter Over Anktiva Claims — Says Ad 'Never Aired At All'</a>

On Monday alone, REPL plunged 64%, ONCO dropped 27%, and HOTH slipped 1%. (Photo credit: Getty Images)

REPL, HOTH, ONCO Stocks Hit 52-Week Lows: What's Driving The Selloff In These Biotech Plays?

On Monday alone, REPL plunged 64%, ONCO dropped 27%, and HOTH slipped 1%, underperforming the broader XLV healthcare ETF.

Equity

These Stocks are Heating Up Fast

Top stocks to trade this afternoon. $ONCO, $KBLB, $ARAI, $EOSE, $ZNTL

Onconetix Stock Skyrockets After Realbotix Ships Vinci-Equipped Robot To Ericsson

Onconetix shares are surging Thursday afternoon after the company highlighted a product milestone from Realbotix, the pending acquisition target it agreed to buy in an all-stock deal.read more...

These Stocks are Turning Heads

A wave of innovation across AI robotics, biotechnology, advanced materials, and clean energy is reshaping the small-cap landscape. $ONCO, $KBLB, $ELAB, $GLMD, $TURB, $GAME

Promising Biotech Stocks To Add to Your Watchlist - March 27th

Danaher, Onconetix, Moderna, argenex, Vertex Pharmaceuticals, Abivax, and Rocket Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...

What's Going On With Onconetix Shares On Friday?

Onconetix (ONCO) shares surge 71% premarket following the Realbotix acquisition update and 1-for-5 reverse split.read more...

<ul class="summary-bullets"><li>Onconetix is currently in the process of merging with Realbotix, a robotics company.</li><li>The company announced that Realbotix robots featured in a trial by Ericsson, signaling new business.</li><li>Stocktwits sentiment for ONCO was ‘neutral.’</li></ul>Shares of Onconetix, Inc. (ONCO) surged 50% in premarket trading on Friday, following a 1-for-5 reverse stock split a day earlier and disclosures suggesting that humanoid robotics firm Realbotix – a company it is merging with – may have been purchased by Ericsson.A Realbotix humanoid robot was featured in a live pre-standard 6G over-the-air trial conducted at Ericsson’s U.S. headquarters in Plano, Texas, according to a press release statement from Onconetix.The robot streamed video and interacted in real time over the test network, demonstrating AI-agnostic integration for cloud and network environments.In February, Onconetix agreed to acquire Realbotix through an all-stock share exchange that will give Realbotix’s parent a majority stake of up to 90% in the combined company.&nbsp;The deal, expected to close in the second half of 2026, effectively acts as a reverse merger with Realbotix and marks the company’s pivot from men’s health and oncology diagnostics to AI-powered humanoid robotics.&nbsp;As of the close of Thursday, Onconetix had a market capitalization of $2.3 million.Retail traders on Stocktwits were noticing the surge in ONCO. “I'm in at $5.46; I expect it to reach $10 today,”&nbsp;<a href="https://stocktwits.com/YoSoyY0/message/648716455">said</a> one user. Traders&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.stocktwits.com/BTC_Will_Hit_14K/message/648716327">speculated</a> that the sharp rise could be linked to the stock’s low float.About 5 million shares of ONCO exchanged hands early Friday, five times the stock’s average trading volume. On Stocktwits, the retail sentiment for the ticker remained ‘neutral,’ unchanged from the previous day. Year to date,&nbsp;<a href="https://stocktwits.com/symbol/ONCO">Onconetix shares</a> are down nearly 60%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/micron-stock-extends-slide-despite-hottest-company-nod-from-trump/cZ3uzd4RIlt">Micron Stock Extends Slide Despite ‘Hottest Company’ Nod From Trump</a>&nbsp;

Traders work on the floor of the New York Stock Exchange (NYSE) on March 02, 2026 in New York City. (Photo by Spencer Platt/Getty Images)

Why Is This Micro-Cap Stock Surging 50% In Premarket?

Onconetix shares rallied after a reverse stock split this week. The company announced that Realbotix robots featured in a trial by Ericsson, signaling new business.

Why Is Onco Micro-Cap Stock Surging 50% In Premarket?

Onconetix shares rallied after a reverse stock split this week.


Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.

ONCO
Onconetix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ONCO News

ONCOOnconetix Inc